Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2005
11/10/2005US20050249704 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
11/10/2005US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
11/10/2005DE102004019662A1 Pharmaceutically active substance, useful for treating tumors e.g. skin cancers, comprises dendritic cells of e.g. spinal marrow (loaded with toxins of spiders of the family Pholcidae) cultivated in the presence of interleukin
11/10/2005DE102004019323A1 Mit toxischen Substanzen beladene dendritische Zellen zur Behandlung von Nierenzellkarzinomen With toxic substances loaded dendritic cells for the treatment of renal cell carcinoma
11/10/2005CA2564512A1 Artificial immune system: methods for making and use
11/10/2005CA2563809A1 Water-soluble, uv-absorbing and/or fluorescent components with very high isoelectric points
11/09/2005EP1593390A1 Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
11/09/2005EP1593388A1 Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1593377A1 Crosslinkable macromers bearing initiator groups
11/09/2005EP1592774A1 Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
11/09/2005EP1592437A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
11/09/2005EP1592373A2 Freeze-dried fibrin matrices and methods for preparation thereof
11/09/2005EP1456354A4 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
11/09/2005EP1261693B1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
11/09/2005EP1246930B1 Replication incompetent herpes virus vectors
11/09/2005EP1212069B1 Improved topical compositions containing extracellular products of probiotic bacteria and uses thereof
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1154692B1 A method of controlling fungal pathogens, and agents useful for same
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP0975227B1 Topical use of probiotic bacillus spores to prevent or control microbial infections
11/09/2005EP0946710B1 Methods of preserving prokaryotic cells and compositions obtained thereby
11/09/2005EP0832195B1 Method of diagnosis of osteoporosis and for testing potential osteoporosis therapeutic agents using standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis
11/09/2005EP0830447B1 Isolation of cells from pancreas tissue using sonication
11/09/2005EP0772455B1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
11/09/2005EP0753068B1 Ligands added to adenovirus fiber
11/09/2005EP0750457B1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694955A Programmable scaffold and methods for making and using the same
11/09/2005CN1694954A Selection and use of lactic acid bacteria for reducing inflammmation caused by helicobacter
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1692912A Biological broad-spectrum antibiotic
11/09/2005CN1226406C Attenuated live neospora vaccine
11/09/2005CN1226039C Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
11/09/2005CN1226038C Technological process of preparing water soluble marine pearl powder
11/08/2005US6962723 High-mineral oyster extract
11/08/2005US6962712 Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent
11/08/2005US6962709 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005US6962698 providing expanded populations of stem cells, as well as progenitor cells, which can be used for hematopoietic cell transplantations, or generation of stem or progenitor cells suitable for genetic manipulations, which may be used for gene therapy
11/08/2005US6962696 Compositions and methods for tumor-targeted delivery of effector molecules
11/08/2005US6962649 Contact assemblies, methods for making contact assemblies, and machines with contact assemblies for electrochemical processing of microelectronic workpieces
11/08/2005CA2293401C A method for depleting viral and molecular pathogens in a biological material
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/05/2005CA2506218A1 Use of plasma proteins concentrates containing vwf with a high proportion of high molecular weight multimers
11/03/2005WO2005103237A1 Method of constructing recombinant herpes simplex virus
11/03/2005WO2005103233A1 Cultured periodontal membrane cell sheet, process for producing the same and method of use thereof
11/03/2005WO2005103231A2 Dentritic cells charged with toxic substances in order to treat kidney cell carcinomas
11/03/2005WO2005103089A1 Fish-origin chondroitin sulfate/dermatan sulfate hybrid chain
11/03/2005WO2005103080A2 Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
11/03/2005WO2005102372A1 Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions
11/03/2005WO2005102369A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005WO2005102368A1 Method for the biodegradation of protein- and/or fat-rich materials
11/03/2005WO2005084691B1 Method of proliferating precursor cells
11/03/2005WO2005079822A3 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
11/03/2005WO2005068614A3 Preparation of fibroblast-populated connective tissue substitute
11/03/2005WO2005056040A3 Systems and methods related to degradation of uremic toxins
11/03/2005WO2005050215A8 Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae
11/03/2005WO2005049056A3 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria
11/03/2005WO2005046454A3 Methods of using gelsolin to treat or prevent bacterial sepsis
11/03/2005WO2005041942A3 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
11/03/2005WO2004093646A3 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245436 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244966 Insulin producing cells
11/03/2005US20050244965 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
11/03/2005US20050244964 Production of neural progenitor cells
11/03/2005US20050244961 Cell culture surface
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244805 Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations
11/03/2005US20050244507 For treatment of organ or tissue hypertrophy; inducible in post-oestrus sheep by clomiphene
11/03/2005US20050244451 Method and device for reducing susceptibility to fractures in vertebral bodies
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244391 Compositions and methods for inhibiting pathogenic growth
11/03/2005US20050244390 Compositions and methods for inhibiting pathogenic growth
11/03/2005US20050244389 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
11/03/2005US20050244388 Suprabasal breast cell with stem cell properties
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244385 Intradermal cellular delivery using narrow gauge micro-cannula
11/03/2005US20050244384 Cellular transplantation for heart regeneration
11/03/2005US20050244382 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005US20050244298 Electrocardiographic aspects of chf treatment
11/03/2005DE202005008010U1 Fermented preparation, useful for medicinal therapy and to kill e.g. bacteria, fungi and virus, comprises grapes cider, additive of herb extract and honey
11/03/2005DE102004017483A1 Verfahren zur Isolierung adulter Stammzellen aus differenziertem Gewebe Method for the isolation of adult stem cells from differentiated tissue
11/03/2005DE102004017476A1 Verfahren zur Herstellung einer Epithelzellen enthaltenden Zellzusammensetzung A process for the preparation of a cell composition containing epithelial cells
11/03/2005DE102004017473A1 Verfahren zur Differenzierung von Stammzellen in Zellen, die ein pankreatisches Hormon produzieren A process for the differentiation of stem cells into cells which produce a pancreatic hormone
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2561691A1 Method of constructing recombinant herpes simplex virus
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1259